GTN Company
GTN innovates a quantum machine learning technology to transform drug discovery.
Investors
Founded Date:
2017-05-17
Technology:
Developing Software
Funding Status:
Seed
Total Funding:
2100000.0
Employee Number:
1-10
Headquarters:
London, England, United Kingdom
Last Funding Date:
2018-11-01
Investors Number:
6.0
Last Funding Type:
Seed
Estimated Revenue:
$1M to $10M
Industry:
Application Software